All Treatments

Ilaris®

Ilaris® works to suppress the production of an inflammatory protein. Increased levels of the inflammatory protein IL-1β cause inflammation resulting in symptoms such as fever, joint pain, and rashes. Ilaris® stops this inflammatory response.

For more information, visit the patient website for this drug. Speak with your healthcare provider to learn if this drug is right for you.

MANUFACTURER:

Novartis Pharmaceuticals Corporation

CLASS:
Interleukin-1β (IL-1β) blocker
WHAT IT TREATS:

 

  • Cryopyrin-associated periodic syndromes (CAPS; including Familial Cold Autoinflammatory Syndrome (FCAS)
  • Muckle-Wells Syndrome (MWS)
  • Neonatal Onset Multisystem Inflammatory Disease (NOMID)
  • Tumor Necrosis Factor Receptor Associated Periodic Syndrome (TRAPS)
  • Hyper-immunoglobulin D Syndrome (HIDS)/ Mevalonate Kinase Deficiency (MKD)
  • Familial Mediterranean Fever (FMF)
  • Adult Onset Still’s Disease (AOSD)
  • Systemic Juvenile Idiopathic Arthritis (SJIA).
PRESCRIBED BY:

Various

HOW ADMINISTERED:
Injection
FREQUENCY:

Monthly or bi-monthly

Length of infusion:
Injection
RELATED DRUGS:
FOR MORE INFORMATION:
Follow a manual added link

855.478.1528

Our mission is to provide clinically exceptional, compassionate, convenient, and cost-effective infusion care to improve the health of our patients in partnership with their physicians

Our vision is to set the nationally recognized standard for the delivery of innovative therapeutics in a patient-friendly environment

CORPORATE OFFICE
1726 Cole Blvd. Suite 250
Lakewood, CO 80401

Find A Location
Refer A Patient
©2022 VIVO Infusion. All Rights Reserved. Website by MANTIKI Creative.
PRIVACY POLICY
AralastElaprase@